Weight loss support for adults with obstructive sleep apnea.

What sleep apnea is and why it matters

Obstructive sleep apnea (OSA) is a condition where the upper airway repeatedly collapses during sleep, causing brief pauses in breathing. The pauses can happen dozens of times per hour. Each one ends in a brief micro-arousal so the brain can restart breathing. The person is usually unaware. The body is not.

OSA affects an estimated 30 million American adults. Most cases are undiagnosed. The classic symptoms include loud snoring, gasping or choking awakenings, daytime fatigue despite a full night in bed, morning headaches, brain fog, mood changes, and unexplained weight gain.

The feedback loop between sleep apnea and weight

Sleep apnea and excess weight feed each other in a vicious circle. Excess fat around the neck, throat, and abdomen makes airway collapse more likely. The repeated arousals fragment sleep, which raises cortisol and insulin, which drive more weight gain. The body becomes more insulin resistant. Hunger hormones shift in unhelpful ways. The cycle accelerates.

The clinical implication is important. Treating one side of this loop often improves the other. CPAP therapy can improve sleep quality and energy. Weight loss can reduce the severity of OSA, sometimes dramatically. Patients who treat both at once tend to do better than patients who try to fix only one.

Why the FDA approval for tirzepatide matters

In late 2024, the FDA approved tirzepatide (Zepbound) for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity. This was the first time a medication was approved specifically for OSA. Previously, the only approved treatments were CPAP, oral appliances, and surgery.

The approval was based on the SURMOUNT-OSA trials, which examined tirzepatide in adults with moderate to severe OSA and obesity. Trial participants who received tirzepatide saw reductions in their apnea-hypopnea index (AHI), the standard measure of OSA severity, alongside the weight reduction expected from a GLP-1 drug. Some participants saw their OSA classification improve substantially.

This approval is for brand-name Zepbound specifically. Compounded tirzepatide is not FDA-approved for any indication, including OSA. If a Puri-affiliated provider determines that compounded tirzepatide may be appropriate for you, they will discuss this distinction.

How GLP-1 medications affect sleep apnea

The connection between GLP-1 weight loss and OSA improvement is mainly indirect: less body fat means less pressure on the upper airway, less inflammation, and a body composition that supports better sleep architecture. There may also be direct effects on appetite and metabolism that improve overall sleep quality.

Brand-name GLP-1 medications like semaglutide and tirzepatide reduce body weight on average through several mechanisms: appetite suppression, slowed gastric emptying, improved insulin sensitivity, and reduced glucagon. The result for some patients is meaningful weight loss that translates into measurable OSA improvement. Compounded versions have not been studied the same way.

What the research has examined

• SURMOUNT-OSA. The trial that supported the FDA approval of brand-name tirzepatide for OSA. Participants on tirzepatide had reductions in apnea-hypopnea index and body weight compared with placebo.
• STEP and SURMOUNT trials. Brand-name semaglutide and tirzepatide in adults with obesity reported substantial average weight reductions over 68 to 72 weeks of treatment.
• Observational data on weight and OSA. Decades of observational research show a strong relationship between weight loss and OSA severity reduction in adults with both conditions.
• CPAP combination data. Some research has examined whether GLP-1 weight loss allows patients to reduce or discontinue CPAP. Decisions about CPAP changes should be made with a sleep medicine specialist after a follow-up sleep study.

These findings describe specific brand-name FDA-approved products. Compounded versions are not FDA-approved and have not been studied the same way.

A real plan for sleep apnea and weight

Get diagnosed properly

If you snore loudly, wake unrefreshed, or have daytime fatigue and weight that will not budge, ask your provider about a sleep study. Home sleep tests are now available for many patients, which is faster and more accessible than the old in-lab option. An accurate diagnosis is the foundation of any treatment plan.

Use CPAP if it is prescribed

CPAP is still the gold standard treatment for moderate to severe OSA. It works the night you start it. If you have been prescribed CPAP, use it. Even if you also pursue weight loss, the CPAP protects your brain, heart, and metabolism while the weight changes happen.

Build the lifestyle foundation

Strength training, protein at every meal, walking after meals, sleep hygiene, and stress management all contribute. Weight loss tends to compound over months when these are in place.

Coordinate with sleep medicine

If you lose significant weight on a GLP-1 medication, your OSA severity may change. Talk to your sleep medicine provider about when to repeat a sleep study and whether your CPAP settings need to be adjusted. Do not stop CPAP on your own.

Side effects and safety considerations

GLP-1 medications most commonly cause gastrointestinal side effects in clinical trials of brand-name products: nausea, constipation, diarrhea, and reduced appetite. Most are mild to moderate and improve with time. Dose escalation is gradual.

OSA-specific consideration: untreated OSA can mask early signs of GLP-1 side effects because patients are already exhausted and irritable. If you start a GLP-1, prioritize CPAP compliance and let your provider know how you are feeling.

Who is NOT a candidate for GLP-1

• Personal or family history of medullary thyroid carcinoma or MEN2.
• Personal history of pancreatitis.
• Pregnancy or breastfeeding.
• Active or recent cancer.
• Severe gastroparesis.
• Active eating disorder.
• Significant medication interactions.

How to think about the decision

• Get diagnosed. A sleep study is the foundation.
• Use prescribed therapies. CPAP and any other prescribed treatments.
• Build lifestyle habits. Strength, protein, sleep hygiene, walking.
• Talk to a provider about GLP-1. Especially if you have moderate to severe OSA and meet weight criteria.

When you are ready, start your assessment.